x

Search for a diagnostic test

* (*) mandatory field

Diagnosis of predisposition to breast and ovarian cancer, search of familial specific mutation and BRCA1/2 Ashkenazi Jewish founder mutations (Panel)

  • Laboratoire d'oncologie moléculaire et pharmacogénomique
  • BATLab - Bâtiment des Laboratoires
  • Hôpitaux Universitaires de Genève HUG
  • Rue Gabrielle-Perret-Gentil 4
  • 1205 GENÈVE
  • SWITZERLAND
  • Director of laboratory : Dr Anne-Laure ROUGEMONT-PIDOUX
  • More information
  • Phone : 0041 (0)22 372 18 30
  • Additional Phone : -
  • Fax : 0041 (0)22 372 18 43
Last update: June 2019

Responsible of diagnostic test

Purpose(s)

Post-natal diagnosis
Somatic genetics

Technical procedure(s)

Molecular genetics
Targeted mutation analysis
Sanger sequencing
Targeted mutation analysis
MLPA based techniques
Sequence analysis: entire coding region
Sanger sequencing
Sequence analysis: entire coding region
NGS sequencing (except WES)
Deletion / Duplication analysis
MLPA based techniques

Quality management

EQA
 EQA

EQA scheme(s) organized by EMQN

BRCA (Familial breast cancer) - full scheme
2014, 2015, 2016, 2017, 2018
Classification of BRCA1 and BRCA2 variants External Quality Assessment Scheme Run 1
2017
Classification of BRCA1 and BRCA2 variants External Quality Assessment Scheme Run 2
2018
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.